ABSTRACT Ventricular fibrillation in patients without recognizable heart disease is uncommon and electrophysiologic data on such patients is limited. Over a 7 year period, five patients (three men and two women, ranging in age from 24 to 52 years) without demonstrable heart disease underwent electrophysiologic studies with pharmacologic drug testing because of single (four patients) or multiple (one patient) documented episodes of ventricular fibrillation. The arrhythmic event was unrelated to myocardial ischemia or infarction, metabolic or electrolyte disturbances, drug toxicity, preexcitation, or prolonged QT syndromes. In all three patients receiving no antiarrhythmic drugs and in two pretreated with amiodarone, a rapid poorly tolerated ventricular tachyarrhythmia requiring cardioversion was induced by programmed ventricular stimulation with up to two extrastimuli. In all instances, addition of either oral quinidine or oral disopyramide prevented the induction of sustained ventricular arrhythmias. All five patients were placed on antiarrhythmic drug regimens found effective during electrophysiologic studies and remained asymptomatic during follow-up periods ranging from 12 to 93 (mean 52) months. We conclude that in the patients with idiopathic ventricular fibrillation in our study: (1) programmed ventricular stimulation reliably replicated the spontaneous arrhythmia, (2) class I antiarrhythmic agents effectively prevented induction of the arrhythmia in the laboratory, and (3) in contrast to the severity of the presenting arrhythmia, a benign clinical course was observed during longterm therapy with class I antiarrhythmic agents. Circulation 75, No. 4, 809-816, 1987. 
IN WESTERN countries ventricular fibrillation usually occurs in patients with cardiac disease, most commonly in those with coronary artery disease, but also among those with cardiomyopathy, valvular or congenital heart disease, preexcitation, or prolonged QT syndromes.' Occurrence of ventricular fibrillation in the absence of recognizable heart disease has been rarely reported in the literature. The first case of apparently idiopathic ventricular fibrillation was probably described by William Dock in 1929.2 Since then isolated cases have been reported, most of them before the advent of cardiac resuscitation techniques and diagnostic catheterization procedures. -9 Electrophysiologic data on such patients is limited to only a few cases scattered among large series of patients with lifethreatening ventricular tachyarrhythmias due to various causes.'0'5 In those patients with idiopathic ven-tricular fibrillation, a low inducibility rate of ventricular tachyarrhythmia was found, and of those with inducible ventricular tachyarrhythmias, electrophysiologic drug testing data are available on only two patients., 131 We here report a series of five consecutive patients with idiopathic ventricular fibrillation inducible in the electrophysiologic laboratory in whom class I antiarrhythmic agents were effective during both electrophysiologic study and long-term therapy.
Patients and methods
Study patients. During the last 7 years (February 1979 to January 1986) five consecutive patients without demonstrable heart disease were referred to our institution for electrophysiologic study because of documented ventricular fibrillation. Ventricular fibrillation occurred 4 days to 1 year before their referral for electrophysiologic study. In all cases, the diagnosis of ventricular fibrillation was made by paramedics or by physicians and defibrillation was required to abolish the arrhythmia. In all patients results ofphysical examination, 12- Protocol of stimulation. During the initial electrophysiologic study the following protocol of stimulation was used: (1) single and double atrial extrastimuli during right atrial pacing at a basic cycle length of 600 msec, (2) incremental atrial pacing until second-degree atrioventricular block occurred, (3) bursts of rapid atrial pacing at the maximum atrial rate allowing 1:1 atrioventricular conduction, (4) single and double right ventricular apical extrastimuli during sinus rhythm and during ventricular pacing at cycle lengths of 600, 500, and 400 msec, and when possible at 700 msec, and (5) bursts of rapid right ventricular apical pacing (5 to 10 beats) up to a rate of 250 beats/min. During subsequent electrophysiologic studies performed to evaluate oral antiarrhythmic regimens only ventricular stimulation was perforned, according to the protocol described above. Ventricular stimulation was performed from the right ventricular apex in all patients and also from the right ventricular outflow tract in the last patient. Drug studies. In two patients the effects of the intravenous administration of disopyramide (2 mg/kg body weight over a 5 min period) on induction of ventricular tachyarrhythmias were assessed at the completion of the initial electrophysiologic study. Programmed ventricular stimulation was repeated after oral administration of quinidine bisulfate (1500 to 2250 mg/day) in four patients and after disopyramide (600 mg/day) in one patient. In all patients serum blood levels of either quinidine or disopyramide were determined during electrophysiologic studies. None of the five patients had other medical problems in the past or a familial history of cardiac arrhythmias or sudden death.
The two patients who suffered cardiac arrest during a stressful situation (Nos. 2 and 4) were treated with a 13-blocking agent (propranolol) by their referring physicians after their cardiac arrests. However, both of them discontinued this treatment a few days (patient 4) or 1 month (patient 2) after hospital discharge. In patient 1 who had recurrent ventricular fibrillation, therapy with amiodarone prevented recurrence of the arrhythmia, but 30 days into therapy, a presyncopal episode strongly suggesting a self-terminating ventricular tachyarrhythmia occurred and prompted electrophysiologic evaluation.
Electrocardiographic data. In all five patients standard electrocardiograms, including QT intervals, were normal. No patient had evidence of short PR interval or Note that a similar response was observed when the basic cycle length was 600 or 500 msec (not shown).
echocardiogram, and radionuclide ventriculogram remained normal in all patients.
Discussion
In the present report we describe five patients who experienced a single or multiple episodes of ventricular fibrillation. In no patient could organic heart disease be demonstrated by extensive invasive or noninvasive cardiac evaluation. During initial electrophysiologic studies performed in three patients on no drug and two on amiodarone, rapid poorly tolerated ventricular tachyarrhythmias degenerating into ventricular fibrillation were induced by programmed ventricular stimulation. In all cases addition of class I antiarrhyth- 15 and rapid atrial pacing in one,"3 while no ventricular arrhythmias could be induced in the remaining 11 patients." ' 13, 4 In our study, consistent results were observed. A sustained poorly tolerated ventricular tachyarrhythmia was induced by programmed ventricular stimulation with up to two extrastimuli in all five of our patients. The reason for the differences in inducibility rates of ventricular tachyarrhythmia in our study and previous reports is not evident. A possible explanation in two of our patients could have been administration of amiodarone before the initial electrophysiologic study, which might have facilitated induction of sustained ventricular tachyarrhythmias. 17 Response to antiarrhythmic drugs. In all of our five patients, a class I antiarrhythmic agent (quinidine or disopyramide) prevented the induction of sustained ventricular tachyarrhythmias and no recurrent tachyarrhythmia was observed during long-term therapy with these agents. Similar beneficial effects of class I antiarrhythmic agents were occasionally observed when they were used empirically2' 4'6 12 or during electrophysiologic testing.'3' '5 Whether the beneficial response to class I antiarrhythmic agents with respect to preventing induction of ventricular fibrillation was a unique characteristic of our patient group is unknown, since there is no study comparing the effects of these agents in preventing inducible ventricular fibrillation in patients with and without organic heart disease. 21 22 In one report,22 initiation of ventricular fibrillation followed ventricular flutter triggered by very early premature ventricular complexes, a situation similar to that observed in one of our patients (No. 1). Interestingly, quinidine prevented induction of ventricular arrhythmias by programmed ventricular stimulation in one of the patients in a previous study.' " The patients in our study differ in several important ways from the Asian patients. These include (1) ethnic differences, (2) a female/male incidence ratio of 2:3, and (3) occurrence of cardiac arrest unrelated to sleep in any of our patients. Therefore, our population group apparently represents a spectrum of patients with idiopathic ventricular fibrillation that is different from that observed in Southeast Asia.
Limitations of study. A limitation of the present study is the small number of patients evaluated. However, to the best of our knowledge, the present series is the largest reporting results of electrophysiologic studies and pharmacologic testing in patients with idiopathic ventricular fibrillation. Another limitation of the study is that, in the absence of endomyocardial biopsy, we do not know whether the arrhythmia in our patients was actually idiopathic in nature or due to occult morphologic cardiac abnormalities. 12, 23 However, it is noteworthy that both the echocardiogram and radionuclide ventriculogram remained normal during the follow-up period, which exceeds 4 years in three patients, suggesting that the arrhythmia was not the early manifestation of a latent cardiomyopathy. In addition, in the few reports of patients with apparently idiopathic ventricular fibrillation in whom an endomyocardial biopsy sample or postmortem examination was obtained, normal findings were noted in most cases. '2' 13, 15, 21, 22 In conclusion, this study has reported a unique subset of patients with idiopathic ventricular fibrillation, a rarely encountered type of arrhythmia. In all patients, a sustained ventricular tachyarrhythmia could be induced during initial electrophysiologic study and induction was prevented by a class I antiarrhythmic agent. In contrast to the severity of the presenting arrhythmia, a benign clinical course was observed during long-term therapy including these agents. However, since very little is known about the natural history of ventricular fibrillation in patients without obvious heart disease, namely how likely such patients are to have recurrent cardiac arrests, some uncertainty remains about the significance to be attached to the longterm drug "responses" observed in our study.
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